Press

IN THE NEWS

Perfuze Millipede88 Aspiration Catheter
July 2025

Perfuze Presents Preliminary Results from MARRS Pivotal Trial at SNIS 2025

Millipede88 Demonstrates High Revascularization and First Pass Effect Rates in MARRS trial

READ MORE
April 2025

Perfuze CEO Wayne Allen features at SmartTRAK

Wayne Allen Discusses the Company, its Novel Technology and Strategies for Growth in the U.S. Market

Read more
April 2025

Pefuze announces two significant milestones in its mission to improve stroke care

Completion of Enrollment in Pivotal US Clinical Study & Joe Rotger as Executive VP of Sales

Read more
March 2025

FDA 510(k) Clearance for Perfuze's Zipline™ Access Catheters & €22M Funding

Perfuze Receives FDA 510(k) Clearance & Secures €22M in Additional Funding

Read more
December 2023

Millipede 070 Aspiration & 2nd Gen Millipede 088 Access Catheters

FDA Clearances for Novel Neurovascular Aspiration and Access Catheters for Stroke Treatment

READ MORE
November 2023

PRESENTED POSTER - SVIN 2023

First-in-Human Experience Using Millipede 088 Aspiration Catheter in Stroke Thrombectomy

Read More
November 2023

MARRS Trial: 1st Patient Enrolled

First Stroke Patient Enrolled in the MARRS Pivotal Clinical Trial at StonyBrook

Read More
June 2023

LATE BREAKING ABSTRACT - SNIS 2023

Multi-Center Experience Using the Millipede 088 Superboare Catheter in Stroke Thrombectomy

Read More
June 2023

Perfuze Announces Appointment of New Chair of the Board

Hooman Hakami Named New Chair of the Board

Read More
February 2023

Millipede 088 Access Catheter

Perfuze Announces FDA Clearance and First U.S. Clinical Use of Millipede 088 Access Catheter

Read More
March 2022

Neurovascular Company Perfuze Raises €22.5M ($25M) Series A for New Stroke Treatment

Series A for New Stroke Treatment. Perfuze Raises €22.5M

Read More
May 2021

Perfuze secures CE Mark on first product

First five patients successfully treated

Read More
March 2021

Published Paper - JNIS

Millipede 088 Optimizes Distal Flow Control Resulting in Potential Improved Revascularization Rates

Read publication
December 2020

Perfuze Wins €4.4M DTIF Grant

Minister Humphreys Announces €65M for 16 Groundbreaking Projects

Read more
December 2020

Perfuze Wins IMDA Award

Perfuze Wins Emerging Medtech Company of the Year

Read more
June 2020

Published paper - JNIS

Preclinical Evaluation of Millipede 088 Intracranial Aspiration Catheter

Read publication
May 2020

Ischemic Stroke: The First Pass Effect

Perfuze Receives Breakthrough Device Designation Status from the U.S. FDA

Read more
September 2019

Medtech Strategist Interview

Ischemic Stroke: The First Pass Effect

Read publication
August 2019

FDA Breakthrough Device Designation

Perfuze Receives Breakthrough Device Designation Status from U.S. Food and Drug Administration (FDA)

Read more
June 2019

€2.5M Horizon 2020 Grant Award

Perfuze receives €2.5M European Innovation Council Funding

Read more
January 2019

€3M Seed Round Investment

Irish Startup Medtech Company has Closed a €3 Million in Seed Investment Round

Read more